VAERS reports by lot

GSK Varicella/Shingles lot 3HT5J: VAERS reports

22 VAERS reports list lot 3HT5J as a GSK Varicella/Shingles vaccine, received between 2019-10-17 and 2021-07-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2529%
Injection-site / Local reaction1416%
Neurological1315%
Dermatological (non-injection-site)1012%
Musculoskeletal89%
Allergic / Anaphylactic67%
Cardiac / Cardiovascular34%
Respiratory22%
Gastrointestinal22%
Psychiatric / Neuropsychiatric22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Illinois3
Florida2
New Mexico2
Michigan1
Alabama1
Virginia1
Rhode Island1
Massachusetts1
New Jersey1
California1
New York1

Reports by month received

2019-101
2019-114
2019-125
2020-013
2020-022
2020-051
2020-071
2020-111
2021-011
2021-021
2021-061
2021-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.